IM Cannabis (NASDAQ:IMCC) Posts Quarterly Earnings Results, Beats Expectations By $0.16 EPS

IM Cannabis (NASDAQ:IMCC) issued its quarterly earnings data on Monday. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.39) by $0.16, Zacks reports. IM Cannabis had a negative net margin of 25.55% and a negative return on equity of 129.86%. The firm had revenue of $9.27 million for the quarter, compared to analysts’ expectations of $14.48 million.

IM Cannabis Price Performance

NASDAQ:IMCC opened at $1.51 on Tuesday. The business’s 50-day simple moving average is $2.04 and its two-hundred day simple moving average is $2.27. IM Cannabis has a 52 week low of $1.50 and a 52 week high of $8.10. The stock has a market cap of $3.37 million, a PE ratio of -0.44 and a beta of 1.03. The company has a quick ratio of 0.59, a current ratio of 0.70 and a debt-to-equity ratio of 0.10.

IM Cannabis Company Profile

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.